Sign Up to Receive the Latest Trading Tips and News from Prosper

    February 21, 2019

    No More Headaches For Zosana Pharma?

    Zosano Pharma Corp (ZSAN) shares rose dramatically today due to the news that the company met the final milestones for its long-term safety study of Qtrypta, an acute treatment for migraine disease. The stock moved up over +180% on extremely high volume, with very little hesitation along the way. Here’s a recap.

    Read Article